chronic pharyngitis
Conditions
Interventions
Experimental group:The experimental group took tablets 3 times a day for 15 days
Control group:The control group received placebo 3 times a day for 15 days
Sponsors
The Affiliated Hospital of Jiangnan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients with confirmed chronic pharyngitis 2.With pharyngeal symptoms (sore throat, itchy throat, dry throat, dry cough, foreign body sensation, aggravated by excessive speech) or pharyngeal signs (pharyngeal edema, mucosal congestion, lymphatic follicle hyperplasia in the posterior pharyngeal wall, discharge) 3.Age between 18 and 65 years old
Exclusion criteria
Exclusion criteria: 1.Patients due to tuberculosis or metastatic lung cancer lesions 2.Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and bronchus 3.Pregnant and lactating women 4.Have recently been taking antibiotics or other medications with throat-clearing properties 5.Failure to take tablets as prescribed or add other medications in the middle of the day and cannot fully cooperate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate of pharyngeal symptoms;Improvement rate of Pharyngeal signs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Adherence; | — |
Countries
China
Contacts
Public ContactFeng Zhang
Outcome results
None listed